hotspot -WSS

hotspot

author：explore 2025-09-29 01:38:30 - browse：96679

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： STAT Virtual Event: ASCO Recap, Live!

entertainment

WSS

STAT Virtual Event: ASCO Recap, Live!

Study: Why relieving medical debt did not improve financial outcomes

The public health thinking behind the CDC’s new Covid guidance

Pharma companies must ensure equitable access to obesity drugs

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

hotspot

hotspot

entertainment

The high cost of giving birth even with insurance

Health care court cases: Humana, Sutter, Novant

In age of alternative facts, a scholarly course on calling out crap

He's 19 months old and has one of the world’s rarest diseases

Trump demands the U.S. pay no more for drugs than other countries … again

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Longer MASH drug regimen improved liver, Akero study finds

FDA approval of Sarepta Duchenne genetic therapy gives me hope

California wildfire smoke linked to 52,000 early deaths, study says

Wikipedia

Harvard's David Sinclair gets blowback over aging

For AI in health care standards, federal regulators join with industry group

Health care court cases: Humana, Sutter, Novant

Microsoft's Peter Lee: Generative AI could help doctors be more human

Stem cell biologist probes earliest stages of human development

Pharma companies must ensure equitable access to obesity drugs

entertainment

knowledge

entertainment

hotspot